Clinical Trials Insurance

Our specialist Clinical Trials Insurance team provide cover for every phase of a clinical trial, with locally compliant coverage given on an admitted basis.

Clinical Trials Insurance solutions

Product description

We understand the complexity, urgency, and specific risks involved in every stage of a clinical trial. Our Clinical Trials insurance solutions provide protection for the sponsors/organisers of clinical trials for drug and medical device testing, covering their legal liability to pay compensation in the event of an injury to a trial participant.

Our team of specialist underwriters, risk consultants, and claims experts — which includes pharmacists and (bio)chemists — support the underwriting of trials worldwide and throughout all phases of a trial: this is complemented by our speedy and reliable quotations and documentation which is crucial for clients in this specialist segment.

Risks covered

We cover liability for all phases of clinical trials for drugs and medical devices as well as non-compulsory studies arising from negligent harm to trial participants or non-negligent harm (also known as no-fault compensation).

Underwriting is based on the agreed protocol and informed patient consent form (ICF) which describe the objectives, design, methodology, statistical considerations, and organization of a clinical trial.

Actively growing

Pharmaceutical

Medical device

Coverage

Indemnity to the insured as “trial sponsor”, including pharmaceutical companies and contract research organizations
Liability for injury to a trial participant, including no-fault compensation where required

Coverage can be provided for the full length of the trial
Fully admitted policies in each territory in local language
Compliance with the local level of cover in all territories

Cautious

Trials involving pregnant Women
Xenotransplants
Gene Therapy

Cell Therapy
Pure surgical procedures (where no drugs nor medical devices are tested)
Trials involving the deliberate transmission of infectious agents to participants

.c-tabs__content-item--noScript { display: block; opacity: 1; } .c-tabs__content-item--noScript .c-tabs__content-item-content { opacity: 1; visibility: visible; height: auto; margin-bottom: calc(24px - 1px); }

�ǿմ�ý Commercial will consider every risk on its own merit. Capacity and coverage offered to individual clients subject to hazard, Nat Cat exposure, grading, terms & conditions. The products and services described on this page may not be available in all locations. This is for your general information only.

Contact our experts

Emerging Risk Trend Talk

Mass timber is critical to decarbonize the construction sector

Even if the material has many advantages, there are still risks such as fire, floods or earthquakes, that need to be mitigated.

�ǿմ�ý Risk Barometer 2024 | Expert risk article

Risk in focus: Fire, explosion

Ranking #6 overall, fire, explosion (19%), up from #9 in 2023, is a significant peril for companies and global supply chains.

�ǿմ�ý Risk Barometer 2024 | Expert risk article

Risk in focus: Political risks and violence

Unsurprisingly, given ongoing conflicts in the Middle East and Ukraine, and tensions between China and the US, political risks and violence (14%) rises up to #8 from #10.

Global I Press release

A cyber event is the top global business risk

�ǿմ�ý Commercial publishes the 13th annual survey of key business risks around the world, according to 3000+ respondents.

Report

�ǿմ�ý Risk Barometer 2024

The most important corporate concerns for the year ahead, ranked by 3,069 risk management experts from 92 countries and territories.

Global I Press release

Leadership change

Petros Papanikolaou will succeed Joachim Müller as CEO of �ǿմ�ý Global Corporate & Specialty SE and �ǿմ�ý Commercial.

Expert risk article

Extreme heat "is changing the rules"

As humanity nudges the global thermostat higher, what are the potential consequences for human health, the workplace, infrastructure, and industry?

Magazine

Global Risk Dialogue

We’re discussing the burning issues and emerging exposures in global risk management, designed to help you navigate through eventful times.

Report

Emerging Risk Trend Talk: Lithium-ion batteries

�ǿմ�ý Commercial’s risk consulting team (ARC) has published a new report focusing on some of the potential risks posed by lithium-ion (Li-ion) batteries.

Global I Press release

�ǿմ�ý appoints Commercial leader for Asia

Christian Sandric will join �ǿմ�ý Commercial as Commercial Managing Director for the Asia region with effect from September 1, 2023.

Global I Press release

New CFO for AGCS

Claire-Marie Coste-Lepoutre will hand over to Oskar Buchauer, currently Head of �ǿմ�ý Group Actuarial, Planning and Controlling and Group Chief Actuary.